| MeSH term | MeSH ID | Detail |
|---|---|---|
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
| Candidemia | D058387 | 2 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Graziano S et al. | The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip. | 2016 | Chemosphere | pmid:26694798 |
| Ellepola AN et al. | Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans. | 2015 Jul-Aug | J Appl Oral Sci | pmid:26398514 |
| Wittekamp BH et al. | Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients. | 2015 | Intensive Care Med | pmid:26459880 |
| Chen Y et al. | Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. | 2015 | Int. J. Cancer | pmid:24798787 |
| Guerra CM et al. | Duration of prophylaxis against fungal infection in kidney transplant recipients. | 2015 | Prog Transplant | pmid:26645924 |
| Austin N et al. | Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. | 2015 | Cochrane Database Syst Rev | pmid:26497202 |
| Tamura M et al. | Involvement of an intracellular vesicular transport process in naked-sgRNA-mediated TRUE gene silencing. | 2015 | Mol Med Rep | pmid:26238202 |
| Fan S et al. | Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. | 2015 | Mycopathologia | pmid:25416649 |
| Zhu Y et al. | Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. | 2015 | Mycopathologia | pmid:25322705 |
| Oncel MY et al. | Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. | 2015 | J. Matern. Fetal. Neonatal. Med. | pmid:25245226 |